Breast cancer risk factors in Queensland women attending population-based mammography screening

被引:10
作者
Protani, Melinda
Page, Andrew [1 ]
Taylor, Richard [2 ]
Glazebrook, Roz [3 ]
Lahmann, Petra H. [4 ]
Branch, Elise
Muller, Jennifer [3 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Discipline Epidemiol & Biostat, Herston, Qld 4006, Australia
[2] Univ New S Wales, SPHCM, Randwick, NSW, Australia
[3] BreastScreen Queensland State Coordinat Unit, Herston, Qld 4006, Australia
[4] Queensland Inst Med Res Canc & Populat Studies, Brisbane, Qld 4006, Australia
关键词
Breast cancer; Risk factors; Family history; Hormone replacement therapy; Complementary medicines; Reproductive factors; HORMONE-REPLACEMENT THERAPY; RANDOMIZED CONTROLLED-TRIAL; ESTROGEN PLUS PROGESTIN; HEALTHY POSTMENOPAUSAL WOMEN; ALTERNATIVE MEDICATIONS; SELF-REPORT; AUSTRALIA; COMPLEMENTARY; HYSTERECTOMY; METAANALYSIS;
D O I
10.1016/j.maturitas.2011.12.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To investigate the prevalence of established modifiable and non-modifiable risk factors associated with breast cancer in Queensland (Australia) women. Study design: Cross-sectional prevalence study of 9792 women (58% of women sent the questionnaire) attending BreastScreen Queensland Screening and Assessment Services between November 2008 and February 2009. Prevalence and 95% confidence intervals were calculated for each risk factor, stratified by age-group (45-49 years, 50-59 years, 60-69 years, >= 70 years). Main outcome measures: First-degree family history (FH) of breast cancer (mother, sister, daughter), reproductive history, behavioural factors, co-morbidities, use of hormone replacement therapy (HRT) and alternatives, and socio-demographic factors. Results: The prevalence of first-degree FH of breast cancer was 16% and a previous diagnosis of breast cancer was 3.5%; both are considered major risk factors for breast cancer. The prevalence of modifiable breast cancer risk factors of moderate risk were: current HRT use (12%), HRT use within the past 5 years (7%), overweight [body mass index 25-29] (33%) or obesity [BMI > 30] (27%), alcohol consumption [>= 11 drinks/week] (10%), sedentary behaviour (70%), and low fruit (34%) and vegetable consumption (69%). These risk factors tended to be higher in younger women (45-49 years) compared to older women (>50 years). Conclusion: Prevalence of risk factors in Queensland women were largely consistent with other Australian and international studies. Hormone therapy use is lower than previously reported estimates in Australia and internationally. The comparatively high prevalence of modifiable lifestyle factors which have been shown to be moderately associated with breast cancer are potential targets for reducing the public health burden of breast cancer. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 41 条
  • [11] Beral Valerie, 2003, Lancet, V362, P419
  • [12] Brown WJ, 1998, WOMEN HEALTH, V28, P23
  • [13] Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia
    Canfell, Karen
    Banks, Emily
    Moa, Aye M.
    Beral, Valerie
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2008, 188 (11) : 641 - 644
  • [14] Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial
    Chlebowski, RT
    Hendrix, SL
    Langer, RD
    Stefanick, ML
    Gass, M
    Lane, D
    Rodabough, RJ
    Gilligan, MA
    Cyr, MG
    Thomson, CA
    Khandekar, J
    Petrovitch, H
    McTiernan, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24): : 3243 - 3253
  • [15] Correlates of soy food consumption at increased risk for breast cancer in women
    Fang, CY
    Tseng, M
    Daly, MB
    [J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2005, 105 (10) : 1552 - 1558
  • [16] Hormone therapy and breast cancer: what factors modify the association?
    Gertig, DM
    Fletcher, AS
    English, DR
    MacInnis, RJ
    Hopper, JL
    Giles, GG
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (02): : 178 - 184
  • [17] Associations between the use of complementary and alternative medications and demographic, health and lifestyle factors in mid-life Australian women
    Gollschewski, S
    Anderson, D
    Skerman, H
    Lyons-Wall, P
    [J]. CLIMACTERIC, 2005, 8 (03) : 271 - 278
  • [18] The use of complementary and alternative medications by menopausal women in South East Queensland
    Gollschewski, S
    Anderson, D
    Skerman, H
    Lyons-Wall, P
    [J]. WOMENS HEALTH ISSUES, 2004, 14 (05) : 165 - 171
  • [19] Recent trends in breast cancer incidence rates by age and tumor characteristics among U. S. women
    Jemal, Ahmedin
    Ward, Elizabeth
    Thun, Michael J.
    [J]. BREAST CANCER RESEARCH, 2007, 9 (03)
  • [20] Use of hormone replacement therapy by postmenopausal women in the United States
    Keating, NL
    Cleary, PD
    Rossi, AS
    Zaslavsky, AM
    Ayanian, JZ
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 130 (07) : 545 - 553